UNIranLogoUNFlagblue
United Nations Iran
سازمان ملل متحد در ایران
UNIranLogoIranFlag larg

22 July 2019 - Iran established the first HIV/AIDS Drug Resistance Laboratory in the MENA region

22 July 2019 - Iran established the first HIV/AIDS Drug Resistance Laboratory in the MENA region

In 2017, the Government of the Islamic Republic of Iran established the first HIV/AIDS Drug Resistance Laboratory in the Middle East and North Africa region.

The Drug Resistance Laboratory was activated in January 2019 to promote treatment and reaching global ambitious treatment targets adopted by Iran.

Drug Resistance test is an essential part of the care and treatment process that requires constant research and innovation. For example, if a patient does not successfully respond to a specific antiretroviral drug which are medicines for the treatment of infection by retroviruses, primarily HIV, this test is used to ensure treatment effectiveness and efficacy.

The eligibility criteria for a patient to do the drug resistance test is to be at least 6 months on treatment without interruption (complete adherence) for the time being.

The Drug Resistance Laboratory is funded by the Global Fund which operates through a Country Coordinating Mechanisms (CCMs) serving as a participatory over side mechanism between government, academia and civil society. This lab is supported by United Nations Development Programme (UNDP) as the fund manager. 

 

Last modified onTuesday, 20 August 2019 10:57
back to top

UN Offices in Iran

News and Stories

Resources

UN Offices Stories

UN Offices Stories

About Us

Follow Us

×

Sign up to keep in touch!

Be the first to hear about our new stories and job vacancies from UN in Iran and our partners.

Check out our Privacy Policy & Terms of use
You can unsubscribe from email list at any time